Broker snap: Positive trend at Glaxo to continue, says RBS
27th Oct 2011 12:23
RBS has hailed the third quarter results of drugs giant GlaxoSmithKline and reiterated its buy recommendation and 1,725p target price on the stock. The company reported on Wednesday that revenues in the third quarter rose by 4% in sterling terms, as it confirmed its full-year guidance. Meanwhile,
Read moreUPDATE: Thursday broker round-up
27th Oct 2011 09:09
Smith&Nephew: Citi reiterates sell. Anglo American: Citi maintains at buy. Invensys: UBS raises to neutral-short term buy from neutral. Lowers target to 225p from 250p. Bellway: UBS keeps at buy, raises target price to 825p from 793p. Lloyds: Credit Suisse cuts target to 31p from 40p, keeps at
Read moreGlaxo beats expectations
26th Oct 2011 12:01
Drug giant GlaxoSmithKline beat expectations with a rise in revenues in the third quarter. For the three month period, revenues were up by 4% in sterling terms to £7.104bn. Broker Credit Suisse had Glaxo down for flat sales during the period. Revenues for the first nine month of the current year we
Read moreGlaxo Smith Kline reports Q3 proforma EPS of 28.5p/share, sales rose 6% -ALERT
26th Oct 2011 12:00
Glaxo Smith Kline reports Q3 proforma EPS of 28.5p/share, sales rose 6%. AB
Read moreUPDATE: Wednesday broker round-up
19th Oct 2011 09:25
GlaxoSmithKline: Credit Suisse ups target from 1,310p to 1,340p, neutral rating kept. BHP Billiton: Credit Suisse reiterates outperform recommendation and 2,800p target. Standard Chartered: Credit Suisse keeps underperform rating and 1,400p target. Diageo: Nomura maintains neutral stance and 1,32
Read moreGlaxoSmithKline eyeing India acquisitions
3rd Oct 2011 08:11
British pharmaceutical giant Glaxo Smith Kline is looking to make acquisition worth as much as $2bn in India, with the aim of consolidating its position in one of the world´s fastest growing markets, says The Times. More to follow ... AB
Read moreFriday newspaper round-up: IMF, Europe banks, business buddies
23rd Sep 2011 06:06
The head of the International Monetary Fund yesterday warned world leaders that they are running out of time to prevent another global slump and urged them to rediscover a "collective momentum" in order to head off disaster. Speaking in advance of the opening of the IMF's annual conference in Washin
Read moreComment: DMGT ponders Northcliffe options
1st Sep 2011 14:20
The closure of the Sunday tabloid the News of the World has given DMGT, publisher of the Mail on Sunday, a big boost. The consequent rise in revenues is likely to make a big difference to full-year profits at Associated Newspapers, DMGT's national newspaper division. Some had speculated that DMGT
Read moreLondon close: Higher finish for FTSE 100
22nd Aug 2011 16:35
The FTSE 100 quickly snapped out of its poor start to finish with gains, though these were somewhat off earlier highs following the start of trading on Wall Street. Gold producers such as Randgold Resources and Petropavlovsk were driven higher by rising prices for the precious metal. Oilfield serv
Read moreSector movers: GSK gives pharma sector a booster
22nd Aug 2011 15:27
The pharmaceuticals and biotechnology sector was among the best performing sectors on Monday, helped by its giant constituent GlaxoSmithKline. The FTSE 100 drugs and healthcare firm announced that it is to buy up over a quarter of UK-based biotech firm Autifony Therapeutics through its wholly-owned
Read moreLondon midday: Stocks post big gains as miners advance
22nd Aug 2011 12:11
Despite a faltering start, the FTSE 100 is now posting near triple-digit gains with resource stocks in particular posting big gains. A surging gold price, which stands just below the $1,900 level drives FTSE 100 miner Randgold Resources to the top of the pile. Oilfield services group Petrofac was
Read moreFTSE 100 Movers: Essar tired of waiting
22nd Aug 2011 12:07
Essar Energy saw its share price take a hit despite announcing that its revenues had soared by more than a third over the first half of 2011. Revenue at the India-focused integrated energy company rose 37% to $6.53bn from $4.76bn in the first half of 2010 but net debt also rose, at $4.62bn up fro
Read moreLondon open: Randgold leads risers as Footsie gains 0.6%
22nd Aug 2011 08:31
After slipping into the red in the opening minutes, the blue chip index quickly swung into the blue, recovering after the steep sell-off seen late last week. A surging gold price, which stands just below the $1,900 level drove FTSE 100 miner Randgold Resources to the top of the pile. Oilfield serv
Read moreLondon pre-open: Nervous start to the week
22nd Aug 2011 07:31
Equities are set to make a nervous start to the week with City traders predicting the blue-chip share index will dip below the 5,000 level, having closed last week at 5,041. A lot of bulls will be pinning their hopes on Federal Reserve chairman Ben Bernanke pulling something out of the hat this we
Read moreGlaxo invests in UK biotech firm
22nd Aug 2011 07:01
Pharmaceuticals giant GlaxoSmithKline is to buy up over a quarter of UK-based biotech firm Autifony Therapeutics through its wholly-owned subsidiary, Glaxo Group. Glaxo is to invest £1.25m in Autifony is exchange for a 25.4% minority equity stake. Autifony will issue 850,000 A ordinary shares to G
Read more